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Summary 
Until recently, reports on MRSA in livestock were mainly limited to occasional detections in 
dairy cattle mastitis. Since 2005 however, studies show the existence of an MRSA clone, 
CC398, which has been reported colonizing pigs, veal calves and broiler chickens and 
infecting dairy cows. Many aspects of its prevalence in pigs are not yet understood. In other 
livestock, colonizing capacity and reservoir status are still unclear.. MRSA CC398 has also 
been detected in meat but, like for other MRSA, the risk this might pose is rather unclear. For 
now, the most worrying aspect of MRSA CC398 seems to be its capacity to spread to humans. 
This might complicate MRSA control measures in human healthcare, posing for urgent 
research into risk factors and transmission routes. Overall, infections with MRSA CC398 are 
much less reported than carriage. More investigation into its pathogenic potential is though 
required. Also the origin and evolution of this clone remain to be revealed. 
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Introduction 
The European conference on MRSA, organised last year by the Federation of Veterinarians of 
Europe, concluded that it was time to tackle MRSA (1). Ten years before, a conference on 
MRSA organised by veterinarians would have seemed rathe  peculiar. However, the ever 
emerging recognition of a new type of MRSA, believed to be of animal origin, and the 
expanding number of reports on transfer of MRSA betwe n animals and humans, has led to 
the growing awareness that MRSA is now a problem in both human and veterinary medicine.  
Looking into the epidemiological aspects of animal MRSA, food production animals (cattle, 
pigs and poultry, further referred to as livestock) are of particular concern. Not only are they 
recorded as the primary source of the newly emerging MRSA type, studies also suggest that 
they are involved in transfer of MRSA strains between animals and humans (and vice versa). 
Indeed, as livestock they are in close contact withpart of the human population (farmers, farm 
co-workers, veterinarians etc.) on the one hand, an on the other, once they have actually 
entered the food chain, they might serve as convenient vehicles for bacterial transfer, possibly 
threatening food handlers and consumers.  
In this review, the current knowledge on the prevalnce, epidemiology, evolution and medical 
importance of MRSA in both livestock and derived food products is summarized. As an 
introduction, the most relevant facts on S. aureus and methicillin resistance are listed, 
followed by a short description of the most frequently used typing methods for both 
methicillin-susceptible S. aureus (MSSA) and MRSA. 
 
MRSA: methicillin-resistant S. aureus 
S. aureus is the best characterized species among the staphylococci, a genus of Gram-positive, 
A-T rich cocci comprising over 50 species and subspecies according to the NCBI Taxonomy 
browser (2). It forms part of the normal staphylococcal flora of humans and various animal 
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species (3,4). S. aureus is also the most important human pathogenic Staphylococcus pecies, 
with clinical conditions ranging from common minor skin infections to severe, often life-
threatening infections (5). 
In animals, S. aureus is one of the three major pathogenic Staphylococcus pecies, together 
with S. (pseud)intermedius and S. hyicus (6). The scale of infections it may be involved in is 
as broad as the number of animal species suffering from it, ranging from pneumonia, joint 
infections, osteomyelitis and septicaemia in poultry (7,8,9), subcutaneous abscesses, mastitis 
and pododermatitis in rabbits (10,11), dermatitis and cellulitis in horses (12,13) to septicaemia 
in pigs (4). However, S. aureus plays its most significant animal pathogenic role as cause of 
intramammary infections in cattle and small ruminants (6,14,15,16), leading to considerable 
economic losses in cattle farming (6,17,18).  
S. aureus owes its strong pathogenic capacities to the presence of a large number of various 
virulence factors (5,19,20,21,22,23,24). In addition, an important impediment in the control of 
S. aureus infections is its tendency to gain resistance to almost all classes of antimicrobial 
agents which it is subjected to (25). Of particular concern is the acquired resistance to the β-
lactamase stable β-lactam antibiotics, historically known as methicill n resistance. Indeed, 
methicillin resistance is caused by the expression of an alternative penicillin-binding protein, 
called PBP2a or PBP2’ (26,27). Since PBP2a shows a very low affinity for almost all β-
lactam antibiotics (27), methicillin-resistant S. aureus (MRSA) is resistant to almost all 
antibiotics of this very comprehensive group, of which many members are still widely used in 
both human and veterinary medicine. 
PBP2a is encoded by the mecA gene (28,29). This gene is localized in a mobile genetic 
element, named the Staphylococcal Cassette Chromosome mec (SCCmec). According to their 
structural composition, SCCmec elements are categorized into different types. Each type is 
marked with a capital number. While initially it seemed that there were only a few different 
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SCCmec-types, it has become clear that more exist, and the nomenclature is rapidly evolving. 
For the moment, eight different types are recognized (Table 1). These types are all based on 
SCCmec-elements found in human MRSA strains.  
 
Molecular typing of (MR)SA 
PFGE 
Pulsed-Field Gel Electrophoresis, assigning isolates into pulsotypes, is presently considered 
as the gold standard method for typing of S. aureus, of both human and animal origin. As a 
standard for S. aureus, the enzyme SmaI is used for the macro restriction (36,37,38).   
MLST 
In MultiLocus Sequence Typing of S. aureus, internal fragments of seven housekeeping genes 
are amplified and sequenced (39,40). Via the S. aureus MLST database (41), a sequence type 
(ST) is assigned (40). Strains that differ in only one or two loci are called Single Locus 
Variants (SLVs) and Double Locus Variants (DLVs), respectively. With ‘Based Upon Related 
Sequence Types’ (BURST) analysis, STs, SLVs and DLVs are grouped into Clonal 
Complexes (CCs). In a CC, the ST that has the highest number of different SLVs and DLVs is 
called the ancestral ST, and the CC is numbered aftr its ancestral ST (42). 
spa-typing 
The polymorphic X-region of the staphylococcal protein A (spa-) gene contains a variable 
number of different repeats of mostly 24-bp (43). In spa-typing, this repeat region is amplified 
and sequenced. The total number of repeats and the sequence of each repeat determine a 
repeat profile, the spa-type (44,45).  
Recently, the Panel on Biological Hazards of the European Food Safety Authority (EFSA) has 
recommended spa-typing for discrimination between MRSA strains from livestock (46). It 
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should be noted that most of these strains are not typable with PFGE following SmaI digestion 
and that they generally belong to the ST398 sequence type (see below). 
SCCmec-typing 
An SCCmec-element is composed of two essential gene complexes: th  mec-complex, 
containing mecA and its direct regulatory genes, and the ccr-complex, responsible for the 
mobility of SCCmec (30,47,48,49,50). According to their structural composition, variants of 
these complexes are distinguished (51). The assignment of SCCmec-types is essentially based 
on which variant of each complex is present (Table 1). This is mostly investigated using PCR 
techniques. Both simplex PCRs (49,52) and multiplex PCRs (53,54,55,56) have been 
developed.  
While the mec- and ccr-complexes show some limited variation, the other parts of SCCmec, 
called J-regions, can vary greatly within and betwen SCCmec-types (51). Based upon 
differences in the J-regions, subtypes of SCCmec are distinguished (e.g. 57,58,59), and these 
can also be detected by PCR (53,54,55,60). 
An important impediment of the abovementioned methods is that they are all based on 
SCCmec-sequences found in MRSA strains from human origin. Recent studies have shown 
that these methods fail to identify some SCCmec-elements found in MRSA strains from 
livestock origin (61,62) and many SCCmec-elements found in methicillin-resistant non S. 
aureus staphylococci (MRNaS) (63,64). As it can thus be expected that additional SCCmec-
types will be described in the near future, the present methods will need continuous updating. 
Indeed, the recently identified SCCmec-types VII and VIII for example (34,35) are not 
included in the current methods.  
 
History of MRSA 
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The history of MRSA is mainly situated in human medicine and started in 1961, when MRSA 
was first isolated in a UK hospital (65,66). From then onwards, MRSA began to spread in 
hospitals all around the world, but at the end of the 1980’s and during the 1990’s its 
prevalence truly exploded in many countries (67,68,69,70). In the beginning of the present 
century, it was shown that the majority of the at th t time known international epidemic 
hospital strains, named Hospital-Acquired MRSA (HA-MRSA), belonged to only five CCs: 
CC5, CC8, CC22, CC30 and CC45 (42), and that they generally possessed one of the larger 
SCCmec-types I-III (71), partly explaining their resistance to most clinically used 
antimicrobial agents (5,72,73). As it is assumed that in humans, the use of large quantities of 
antimicrobial agents can lead to selection and emergence of organisms resistant to these 
agents (74), prolonged antimicrobial therapy has been designated a risk factor for the 
acquisition of HA-MRSA (75,76), as have prolonged hospitalization, care in an intensive care 
unit, surgical procedures, and close proximity to apatient in the hospital who is infected or 
colonized with MRSA (77,78). 
While the problems with HA-MRSA were not at their full width yet, a second phase in the 
history of MRSA dawned halfway the 1990s, when MRSA infections involving strains 
different from HA-MRSA were increasingly documented in non-hospitalized patients 
(79,80,81,82,83). Such cases, called Community-Associated or Community-Acquired MRSA 
(CA-MRSA), have since been reported worldwide. Although there has been some discussion 
about the origin of several (early) cases (84), analysis of the genetic background of CA-
MRSA strains has shown a clear distinction from typical HA-MRSA, as they predominantly 
belong to ST1, ST8, ST30, ST59, ST80 and ST93 (85).In addition, CA-MRSA mostly 
possess the smaller SCCmec-types IV and V (32,52,86), which is assumed to be at l ast partly 
explanative for the generally more antimicrobial susceptible phenotype of CA-MRSA. The 
carriage of the genes encoding Panton-Valentine leukocidin (PVL), a cytotoxin believed by 
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many authors to be responsible for severe infections of the skin and soft tissues (90,91) and 
highly lethal necrotizing pneumonia (92,93,94), is considered to be typical for certain CA-
MRSA strains (85,87). The pathogenic role of PVL is though still under discussion (88,89). 
Compared to HA-MRSA, CA-MRSA also seems to possess different risk factors for 
acquisition, as it has been most often reported in populations of intravenous drug users, men 
who have sex with men, prison inmates, contact sport teams, military recruits and children 
(80,95,96,97,98,99,100,101). 
Although MRSA was first isolated in animals already in 1972, from Belgian cows with 
mastitis (102), animals seemed not to play a role of significance during most part of the 
history of MRSA. Based on the results of at that time available biotyping methods, it was 
concluded that those first isolates were from human origin (103). Also in occasional later 
reports on MRSA isolated from animals (mainly companion animals) the strains were mostly 
human genotypes (104,105,106,107,108). This seemed not surprising, seen the increasing 
prevalence of MRSA in non-hospitalized community memb rs at the time. Although since, 
the problem of (human) MRSA in companion animals ha rather expanded, whole new 
concerns raised in 2005, when MRSA was found associated with pig farming in the 
Netherlands (109). 
This third phase in the history of MRSA was initiated ‘accidentally’, by the unexpected 
isolation of MRSA from a family of pig farmers and one of their pigs (109). Results of 
subsequent investigations showed that pig farmers from the same geographical region were 
carrying MRSAin a >760 x higher carriage rate than the general Dutch population..  
Remarkably, PFGE analysis of the MRSA strains showed that they were all resistant to 
digestion with restriction-endonuclease SmaI, but spa typing and Randomly Amplified 
Polymorphic DNA (RAPD) analysis proved that all strains were closely related to each other 
(109). When a few months later a pig farmer from another region together with an unrelated 
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veterinarian mostly working with pigs, that veterinarian’s son and a nurse treating this boy 
were found also to be colonized with a related MRSA strain , it was concluded that pig 
farming might pose a significant risk for MRSA carri ge in humans (109).  
At that time, the importance of specifically this type of MRSA was not clear, and also the 
extent of the problem concerning farming, of pigs as well as other animals, could only be 
guessed at. In the following months and years however, a multitude of reports, from the 
Netherlands as well as many other countries, showed that MRSA of this type not only had 
spread among pigs, other animal species (veal calves, chickens, horses, dogs, rats) and 
humans related to farming 
(61,110,111,112,113,114,115,116,117,118,119,120,121,12 ,123,124,125,126), but was also 
capable of causing disease, in animals (62,115,119,127,128,129) as well as humans 
(116,119,130,131,132,133,134). It is now understood hat this MRSA is disseminating 
clonally, possessing some typical features: 
- non-typability with standard PFGE with SmaI-digestion; this was shown to be due to the 
presence of a new restriction/methylation system leading to protection from SmaI 
digestion (135). It is not clear how this novel system was achieved. The specific system 
was thus far unknown for S. aureus and even for the genus Staphylococcus (135).  
- being mainly MLST ST398. Very seldom, SLVs or DLVs, like ST752 and ST753 have 
been reported (116). All strains thus belong to the same CC, CC398 (41,116,130). 
- various spa-types; the authors have knowledge of 25 different y t related spa-types that 
have been reported to belong to CC398 (Table 2 and T ble 3). The majority of these types 
are combinations of repeat sequences r02, r08, r16, r24, r25 and r34 (Table 2). Some other 
repeats are present less frequent but are closely related to some of the common repeats 
(Table 3). As new spa-types have continuously been reported so far, it seems likely that 
more types will be described in the future. 
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- carriage of SCCmec-type IVa or V; some studies also found SCCmec-type III 
(61,116,122). However, the method they used, a multiplex PCR described by Zhang et al. 
(54), is under debate concerning its reliability for typing SCCmec-type III (139). Also, 
several studies have stated that SCCmec-type IV was present (116,123,127,136,140). No 
subtyping was performed by these authors, so it is not clear whether their strains belonged 
to IVa. To date, no other subtype than IVa has been fou d in this MRSA clone. 
Remarkably, the SCCmec-elements also often appear to be non-typable with the common 
SCCmec-typing techniques (61,62,116). 
- general absence of Panton-Valentine leukocidin (PVL), differentiating these strains from 
typical CA-MRSA strains. Also many other virulence(-associated) factors, known to be 
present in typical HA- or CA-MRSA strains, have been shown to be absent in MRSA of 
ST398 (141,142). Despite this large absence of virulence(-associated) factors, MRSA 
ST398 strains have been found causing disease, in both animals (62,115,119,127,128,129) 
and humans (116,119,130,131,132,133). It is as yet unclear which factors are involved. 
More investigations are urgently needed to elucidate this.  
- resistance against tetracycline, and frequent resistance against macrolides, lincosamides, 
aminoglycosides and trimethoprim. Also fluoroquinolone-resistance has been reported 
(61,62,112,119,123,127,132).  
Some different descriptions have been proposed for re e ring to these MRSA strains. Because 
of their typical resistance to SmaI digestion, they are sometimes called Non-Typable MRSA, 
NT-MRSA. However, there are arguments against the use of this description. First, it is 
obvious that these strains are not non-typable. Many other techniques have proven to be 
useful for typing the so-called NT-MRSA (109,111,143,144). Moreover, when using other 
restriction enzymes, positive results can be obtained with PFGE (138,144). Second, from 
bacteraemia blood samples from a Hong Kong hospital collected in 2000-2001, two MRSA 
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were isolated with a clonal background formerly unknown for Hong Kong, ST398 (145). 
They however proved to be digestible by SmaI, and were assigned to pulsotype I.  
It seems reasonable that the clonal background should settle the name. ST398 is a type that 
was virtually absent from the human population before the initial reports in the early 2000s, 
and typing data seems to support that its recent prsence in humans is a direct result of its 
emergence in livestock, and more specifically, pigs (116,146,147). This supports a livestock 
origin of these MRSA strains. Consequently, livestock-associated MRSA (LA-MRSA) 
appears to be the most appropriate description, and this name designation will be used in the 
further text. 
 
MRSA in livestock  
Although LA-MRSA is the most important MRSA clone rsiding in livestock, it is not the 
only MRSA type that has been reported in livestock. Below a general overview is given of 
MRSA in livestock.  
 
Pigs 
LA-MRSA seems to be the predominant MRSA strain in pigs, as among numerous recent 
studies only two mention the detection of non-LA-MRSA in pigs. In Singapore, one ST22-
MRSA-IV was isolated from pigs (115). ST22-MRSA-IV had been found before to be 
increasingly important in the hospital population of Singapore and is also known as UK-
EMRSA-15, one of two major hospital clones in the UK (132), indicating human 
contamination of the pigs. In Canada, 14% MRSA isolates from pigs appeared to belong to 
the human epidemic CMRSA-2 clone, while 74.4% of the isolates were LA-MRSA (121). 
The remaining strains belonged to rare clones, not rela ed to LA-MRSA or CMRSA-2 (121). 
 12 
Most reports on LA-MRSA in pigs come from the Netherlands (111,127,131,136). In Europe, 
LA-MRSA has further been found in pigs in Germany (119,129), Denmark (112) and 
Belgium (117,120), while outside Europe, in Canada (121,148), Singapore (115) and the 
United States (149).  
Several studies have described colonization of healt y pigs. At pig level, the reported 
carriage-rates vary considerably between countries, from 1% in Denmark (112), 18.6% in 
Canada (121), to approx. 40% in Belgium and the Netherlands (111,117). Farm level rates are 
generally higher: 66% in Denmark (112), 68% in Belgium (117) and 45% in Canada (121). 
However, these figures have to be interpreted carefully, as the number of farms included in 
the studies varied considerably, from 3 in Denmark (112), 20 in Canada (121) to 50 in 
Belgium (117). In the Netherlands two studies found very different farm level prevalences, 
81% positive farms (44 out of 54 farms) (131) compared to 23% positive farms (7 out of 31 
farms) (136). Both studies however used different culture techniques. In addition, the result of 
the former study could have been increased by cross-c ntamination in the slaughter house, 
where the sampling was done (131). In the latter study on the other hand, the majority of 
farms belonged to the ambulatory clinic of the Veterinary Faculty of Utrecht, and in these 
farms the antimicrobial use is generally more restricted than in other farms, implying a 
possible underestimation of the farm-level-prevalence (136).  
Limited other investigations have been performed to elucidate factors possibly influencing 
LA-MRSA prevalences in pigs. In one study, different farm management systems showed 
significant differences in LA-MRSA prevalences, with LA-MRSA being detected in 94% of 
open farms (fattening farms) compared to 56% in closed farms (farrow-to-finish farms) (117). 
In another study however, LA-MRSA prevalence seemed to differ greatly when comparing 
among two closed farm systems; one production system was highly MRSA positive and the 
other system appeared MRSA negative (149). As a cause for this, differences in other aspects, 
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such as breed and herd size, were suggested by the aut ors (149). A third factor they 
suggested  was the origin of the sows. The sow herds of both production systems had been 
repopulated shortly before the date of sampling. As it was, part of the sows of the MRSA 
positive system had been imported from Canada, where pigs have been found to be affected 
by LA-MRSA (121). The sows from the other system cae from Michigan, U.S. (149). 
Although the authors could not give epidemiological evidence, LA-MRSA was thus possibly 
brought into the positive farm via import of affectd live swine or pork products. This 
however should not mean Canada is the origin of LA-MRSA in the U.S., as at that time the 
presence of LA-MRSA in other regions of the U.S., such as Michigan, had possibly not been 
investigated.  
Although certainly more studies are required to reliably assess the influence of farm 
management and related aspects on LA-MRSA prevalence, these studies suggest an important 
role for national and international pig trading in the dissemination of LA-MRSA in pig 
farming. This was also suggested by a Dutch study, in which indications were found that 
finishing and farrowing farms may get colonized by LA-MRSA through the purchase of 
colonized pigs from their supplier farms (136). A recent study also showed that piglets from 
an LA-MRSA positive sow were 1.4 times more likely to be colonized with LA-MRSA than a 
piglet from a negative sow (148). Purchase of LA-MRSA positive sows will thus facilitate the 
spread of LA-MRSA in a farm.  
Another factor that might be implicated in LA-MRSA prevalence in pigs is age. In a Belgian 
study, the probability of being MRSA positive was significantly higher for piglets than for 
both sows and fattening pigs (117). The influence of age was also investigated by a recent 
Canadian study, in which the dynamics of MRSA colonization in piglets was investigated 
over time (148). All MRSA appeared to be LA-MRSA and the colonization rates were found 
to be low initially (below 10%) but increased over time, to 35% positive piglets prior to 
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weaning and a peak of 64% positive piglets at the age of 42 days. At the last day of sampling 
(age 70 days) 41% of piglets carried MRSA. However, an earlier Canadian study contrarily 
found no significant difference in MRSA prevalence between three different age groups of 
pigs, i.c. suckling pigs, weanlings, and grower/finisher hogs (121). More investigations are 
thus required to elucidate any possible influence of age. 
LA-MRSA has also been isolated, albeit rarely, from infections of pigs. These involved skin 
infections such as exudative epidermidis (127) or others (115,129) but also infections of the 
urogenital tract (129) and the uterus and mammary gl nd (129). For the moment it is unclear 
which virulence factors are involved. Yet, considerng the far higher number of unaffected 
carriers, LA-MRSA seems to be rather a colonizing strain of pigs.  
 
Cattle 
In cows, S. aureus plays a significant role as a major cause of mastitis (6) and most studies on 
MRSA in cattle concern isolation of MRSA from mastiti . Unlike the development in 
humans, the first detection of MRSA in mastitis (102) was not the beginning of a steady 
increase in MRSA prevalence. Although more MRSA wasdetected in some of the originally 
positive farms on several occasions in the two years after the first isolation (103) and in the 
subsequent years MRSA was still detected in Belgian routine antibiotic susceptibility tests 
(150), the prevalence fell and in 1982-1983 MRSA was no longer detected in Belgium, an 
absence which remained for nearly 25 years (62,150). Also in other countries no MRSA was 
reported in mastitis for a long time. Reports came more frequently from the early 2000s on.  
From these reports, it is hard to estimate an overall prevalence of MRSA in mastitis. First, 
there are often inconsistencies in laboratory methods in different studies, making it difficult to 
make viable comparisons. The most important example of this is the lack of control on the 
presence of the mecA-gene in many studies, which can result in unreliable data (151), for 
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example because of the heteroresistance of Staphylococcus aureus to methicillin (152). 
Several studies reporting MRSA in mastitis not or only partially verified the presence of the 
mecA-gene (153,154,155,156), and should thus be treated wi h the greatest care when 
estimating the prevalence of MRSA in mastitis. Also the isolation procedures tend to differ 
considerably between different studies.  
Second, when considering studies in which presence of mecA was confirmed (= true MRSA), 
other essential data can be missing. In France, Alves et al. recently detected true MRSA in S. 
aureus strains collected from mastitic milk and from the nares of cows. They did however not 
mention from which body site the MRSA strains originated (157). 
Third, prevalence of true MRSA in mastitis can be assessed at different levels, i.e. quarter-, 
cow- and farm-level. Some studies do not provide sufficient data to know on which level their 
data should be interpreted. For example, a Hungarian study found true MRSA in milk samples 
from subclinical mastitis originating from only one farm, but it was not elucidated whether all 
samples originated from different cows or from different quarters. Moreover, it was a 
longitudinal study, with samples being taken over a two-year period (158). In South Korea 
true MRSA was found in bovine milk specimens. However, the total number of milk 
specimens was not given and not all samples originated from mastitis (159). In another report 
the same author found true MRSA in a specific number of milk samples from different cows  
but also in this case the number of milk samples originating from mastitis cases was not 
specified (160).  
Only two studies, from South Korea, give adequate information, and they show that the 
quarter-level prevalence of MRSA in mastitis is very low, ranging from 0.18% (58) to 0.4% 
(161).  
A factor that not so much influences a correct estimation of the MRSA prevalence in mastitis 
but is important from an epidemiological point of view is the origin of the MRSA strains. 
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Using biotyping methods the first detection of MRSA in mastitis was found to be presumably 
of human origin (103). Yet, from the other above mentioned studies, many did not include 
information or hypotheses on origin of the strains (154,155,156,161). Those that did mostly 
found a likely human origin (58,158,159,160), although the presence of bovine specific 
MRSA strains was also suggested (153,157). Recently however, LA-MRSA has been found to 
be present in Belgian cases of clinical and subclinical mastitis (62). It was shown that nearly 
10% of Belgian farms suffering from S. aureus mastitis was affected by LA-MRSA and that 
the farm-level prevalence of LA-MRSA in positive farms varied between 3.9% and 7.4% 
(62). Also in Germany LA-MRSA has been found in mastitis (141).  
As the colonization capacity of LA-MRSA in dairy has not yet been investigated and the 
current data on LA-MRSA are still sparse, the exact burden of LA-MRSA for dairy cattle 
farming is not yet clear. Yet, it can be reasonably suspected that the infection of dairy cattle 
with LA-MRSA will expand in the future. The many species in which it has been found 
shows that LA-MRSA is relatively unspecific in its host colonisation and might thus very well 
find a host in cows. In addition, although this hasnot been substantiated by evidence, the 
small timescale in which LA-MRSA has attained these different species and has spread to 
different countries suggests that LA-MRSA can spread sily. As β-lactam antibiotics, β-
lactamase-sensitive as well as -stable, are among the most frequently used antibiotics for 
treatment of mastitis and also tetracyclines, macrolides and aminoglycosides are often 
included in the treatment or prevention schedule (162, 63,164), the typical resistances LA-
MRSA exhibits against these antibiotics might cause serious problems for treatment of 
mastitis. Because risk factors (repeated or enduring co tact with a contaminated source) and 
transmission routes (the milking machine and hands of the farmer) for the spread of normal 
mastitis-causing S. aureus are likely to be the same for spread of LA-MRSA, future research 
might want to focus on these topics. 
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While we have found no real evidence that non-LA-MRSA has ever been isolated from 
another body part of living cattle than the udder, LA-MRSA has been found in the nose of 
beef calves. In the Netherlands, in one farm 50% of the beef calves appeared to be carrying 
LA-MRSA in their nose (114). As for dairy cattle, more research is still needed to elucidate 
whether LA-MRSA has a true reservoir in veal calves. 
 
Poultry 
The first report on MRSA in poultry came from South Korea, where MRSA was isolated from 
chicken arthritis cases. With RAPD typing the MRSA strains appeared highly similar to each 
other, and they were suggested to share a common ancestor with MRSA strains isolated from 
humans and bovine milk (160). Three years later three MRSA were reported again in South 
Korea (159). On the basis of a comparison of the sequence of the mecI-gene with human 
strains, one strain was suspected to be human. The other had a mecI-sequence that was 
previously undetected in humans suggesting these strain  were animal specific. 
More recent reports concern the detection of LA-MRSA in or associated with poultry. First, a 
LA-MRSA strain was isolated from chicken droppings in the Netherlands (113). Then, LA-
MRSA was detected in Belgian poultry, where  LA-MRSA was found in a collection of recent 
S. aureus isolates from nares and cloaca of industrial broile s in Belgium (61). In another 
Belgian study LA-MRSA was found in broiler chickens but not in laying hens (124). For the 
moment the reasons for it are unclear. Though, as antibiotics are seldom used in layers, 
differences in antibiotic use may account for it. 
The amount of data is currently too sparse to draw consistent conclusions on LA-MRSA in 
poultry. It is unclear whether LA-MRSA has an impact on animal and poultry farmer health. 
More investigations are needed to further elucidate the epidemiology. 
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MRSA on livestock-derived food products 
Besides its importance as hospital and community pathogen, S. aureus is also a well-known 
cause of food intoxication (165,166). S. aureus food poisoning is the result of the production 
of staphylococcal enterotoxins, of which many types have been found in strains of S. aureus 
(166,167). Although these enterotoxins function as superantigens, i.e. they cause 
immunosuppression and trigger nonspecific proliferation of T-cells, leading to high fever, the 
clinical outcomes of S. aureus food poisoning are mostly relatively mild (165). Therefore, it is 
estimated that the actual number of foodborne illnesses caused by S. aureus is much higher 
than the reported number (165). 
In contrast, MRSA food poisoning is very rare. The only report on MRSA food poisoning 
comes from the United States, where three adults becam  mildly ill after they had eaten 
coleslaw contaminated with an MRSA producing enterotoxin C (168). This strain probably 
came from a food handler in the market place where the coleslaw was bought and was 
possibly of hospital origin (168). 
MRSA of human origin can also be found on meat. In he Netherlands, an MRSA strain 
isolated from raw pork appeared upon genotyping to be identical to a well-known human 
clone, USA300 (ST8-MRSA-IV) (169). Also in the United States MRSA clone USA300 was 
found on raw pork (170). In that study also another widespread human clone, USA100 (ST5-
MRSA-II), was found on raw pork and on a sample of raw beef. Further, in South Korea 
MRSA of a likely human origin was found twice on chicken meat (160,171). Also in Jordan 
MRSA of suspected human origin was found on chicken m at (172). All these studies did not 
report whether the detected strains were capable of producing enterotoxins. In Japan however, 
an MRSA strain of human origin isolated from raw chicken samples appeared capable of 
producing enterotoxin C (173).  
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The aforementioned studies did not elucidate the source of contamination of the meat. The 
investigated meat was selected from retail shops or meat markets. However, no research was 
done on presence of MRSA in the people working in these places. There is though one study 
from Taiwan in which 18 meat market workers were shown to carry MRSA in their nose 
(174). Yet, in this study no meat was examined.  
As humans are capable of contaminating meat, it seem  r asonable that human MRSA on 
meat can also contaminate persons handling or eating co taminated meat. This could be an 
important route for transmission of MRSA in the community or the hospital. The risk this 
could pose was illustrated by a Dutch hospital outbreak of MRSA in two hospital units. The 
outbreak was likely initiated by transmission of MRSA via food contaminated by an MRSA 
positive healthcare worker involved in food preparation (175). In total, fourteen healthcare 
workers and 27 patients were attained and of 22 patients that subsequently developed clinical 
disease, four died. The initial food specimen involved could however not be revealed (175).  
Indeed, in this regard, it needs to be kept in mind that proving a food specimen was a source 
of MRSA contamination is likely to be a difficulty in studies investigating this. Per definition, 
food is sold or bought to eat. Consequently, unless (clinical) results follow immediately upon 
eating or handling contaminated food specimens, contami ation is likely to pass unnoticed 
initially and by the time it is noticed, if it ever is, the contaminated specimen will often be 
sold, eaten or thrown away. Hence, contaminated fooc uld hitherto have been much more 
involved in cases of MRSA colonization or infection than has been reported until now. Thus, 
even though of the above mentioned studies on human MRSA strains on meat, none reported 
contamination events due to contact with the contamin ted meat, it is perhaps premature to 
suggest that meat contaminated with human MRSA poses l w or no risk for consumers. More 
investigations, for instance under experimental settings, are needed to gain more insight in the 
actual risks. Opposite, it also seems unnecessary to make too much commotion about the risks 
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of contaminated food. Performing the normal hygienic measures when handling foods should 
suffice until thorough research proves otherwise. 
Of special interest in these matters is the emergence a d wide spread of LA-MRSA in 
livestock, which raises the question whether these strains are also present on derived meat and 
via this way could find an entry key for a larger sp ead in the human population. A Dutch 
study proved relatively early that LA-MRSA could bepresent on pork (169). A very recent 
and much larger Dutch study confirmed this, and showed in addition a very wide spread of 
LA-MRSA on many different meat products. In the study, 2217 raw meat products were 
investigated and MRSA strains were isolated from no less than 264 samples (11.9%). An 
overwhelming 85% of the strains were LA-MRSA (137). The highest isolation percentages 
were found in turkey, chicken and veal meat. Not only is this clear proof that LA-MRSA has 
found its way into the food chain, it is also remarkable because LA-MRSA was present in 
turkey, lamb and sheep meat while currently no living carriage of LA-MRSA has been 
reported in these animals. Despite this relatively high number of meat contaminated with LA-
MRSA, so far there are no signs that this has contributed significantly to the dissemination of 
LA-MRSA to humans. This may be at least partly due to the very low numbers in which LA-
MRSA was found present on the meat (137). However, th  comments concerning the 
difficulties of proving this, as in the case of human MRSA on meat, also count for LA-
MRSA. 
In addition to meat, another livestock derived food product that could lead to MRSA food 
intoxication or serve as vehicle for MRSA transmission is raw milk, when contaminated raw 
milk is used for the production of cheese. This wasreported in Italy, where two MRSA strains 
of unknown origin were found in dairy cheese products (176). As these strains were found to 
harbour genes for expression of common staphylococcal enterotoxins, they had the potential 
to cause food poisoning (176).  
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Origin and molecular evolution of LA-MRSA 
LA-MRSA seems to be primarily associated with pigs. However, since little is known on 
healthy carriage of S. aureus in pigs and the staphylococcal species dominating in infections 
of pigs is S. hyicus (4,6), the emergence of LA-MRSA in pigs was fairly unexpected, and 
brings up questions on origin and evolution of MRSA T398. 
 
From MSSA ST398 to MRSA ST398 
As both MRSA ST398 and MSSA ST398 have been described, t can be assumed that MRSA 
ST398 evolved from MSSA ST398 by acquisition of SCCmec. Two issues relate to this event: 
the origin of MSSA ST398 and the circumstances concerning the acquisition of SCCmec by 
MSSA ST398. Unfortunately, very little data are available to elucidate both these issues.  
Until now, MSSA ST398 has only been described in humans (41,147,177) and in pigs 
(112,147), suggesting one of these species is the original host of MSSA ST398. Although it 
has been more often and way earlier (already in 1997) (41) described in humans than in pigs 
(first time in 2005) (147), the results of an early French study support the idea that MSSA 
ST398 is primarily pig-associated. In that study ST398 was found among certain MSSA 
clones that were prevalent in healthy pig farmers but not in healthy non-farmer controls. As 
ST398 MSSA strains were also present in infections from pigs, animal to human transmission 
of this clone was suggested (147). Furthermore, the low number of detections and the 
relatively late date of the first description in pigs can easily be due to the fact that, following 
from the low pathogenic relevance of S. aureus in pigs, there has been little reason for MSSA 
(ST398) isolates to be detected in pigs. Nonetheless, it eems that more data are necessary to 
reliably conclude that MSSA ST398 is essentially pig-specific. Unfortunately, contrarily to 
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humans, very few databases of S. aureus strains isolated from pigs over time are available, 
making it hard to assess the prevalence of MSSA ST398 in pigs before the recent reports.  
The issue of SCCmec acquisition by MSSA ST398, evolving then into MRSA T398, is 
equally hard to address. In general, little is know to date on the origin of SCCmec and mecA 
and on the epidemiology and mechanisms of SCCmec acquisition. Apart from the very origin 
of mecA in S. aureus, which is assumed to have involved a mecA homologue present in the 
coagulase-negative species Staphylococcus sciuri (178,179,180,181), it is generally assumed 
that the presence of SCCmec in a certain MRSA clone has been preceded, somewher  in the 
evolution of that clone, by a horizontal transfer of SCCmec from another source (71). This 
source could then be another MRSA strain carrying the specific SCCmec element or, which is 
often suggested, a methicillin-resistant non S. aureus Staphylococcus (MRNaS), in which 
various SCCmec elements are known to be present (182,183,184) and which thus could 
function as a reservoir for SCCmec. Very little is however known on such transmission 
events. Although the cassette chromosome recombinase(s) contained in the ccr-complex of 
SCCmec are known to be responsible for integration and excision of the entire SCCmec 
(31,32), actual transmission events of whole SCCmec elements are very hard to prove, and the 
few reports on such events largely depend on interpretation of indicative epidemiological and 
typing data. For example, using such data, a Swedish study recently suggested horizontal 
transfer of an SCCmec type V between clinical isolates of methicillin-resistant S. 
haemolyticus and MSSA ST45 (185). Yet, without further evidence, th  role of MRNaS in the 
horizontal transfer of SCCmec to MSSA and the frequency of SCCmec transmission events 
between staphylococcal strains remains merely a case of peculation. 
The same accounts for explaining how LA-MRSA evolved from MSSA ST398 strains. With 
the assumption that MSSA ST398 is originally pig-associated, it can be proposed that 
SCCmec transmission occurred in pigs, with MRNaS or MRSA as donor species. However, 
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very little literature is available on presence of MRNaS in pigs, leaving any such donor 
species to the guess. Also, to date, MRSA strains other than LA-MRSA have rarely been 
reported in pigs (see above). Nonetheless, as LA-MRSA mostly harbours SCCmec-types IVa 
and V and the smaller SCCmec types IV and V are considered to be typically carried by CA-
MRSA, human CA-MRSA strains could very well have been the donor species. Indeed, 
human MRSA strains could be present more frequently i  pigs, because, similarly to MSSA 
in pigs, the availability of few reports could be due to a lack of studies investigating MRSA in 
pigs. However, an interesting idea is that the acquisition of SCCmec by ST398 MSSA did not 
occur in pigs but in humans. This would agree with the earlier detection of ST398 MRSA in 
humans than in pigs. Indeed, before the first report on LA-MRSA in pigs (109), ST398 
MRSA was detected in a Dutch woman (41,131) and in a French pig farmer (147). A possible 
course of events could thus have been that after transfer to one or more humans, most likely 
farmers, an ST398 MSSA strain from pigs acquired SCCmec from a CA-MRSA strain, and 
after recolonization of one or more pigs, such ST398 MRSA strain started to spread among 
other pigs. That the first detections of MRSA ST398 occurred in the Netherlands and France 
does not necessarily imply that these events took place in one of those countries. Especially 
the Netherlands seem an unlikely country, as the MRSA prevalence in both the hospital and 
the community is one of the lowest of the world.  
Regardless of the exact facts of these matters, the fact that multiple SCCmec-types have been 
identified in LA-MRSA indicates that LA-MRSA must have arisen on multiple occasions 
from MSSA ST398 strains. This brings along other questions. It is for example not clear 
whether the two most frequently detected types, IVa and V, were already present from the 
very beginning, or whether one element was responsible for the first cases and the other was 
acquired later on. The very first reports of ST398 MRSA did not include information on the 
SCCmec-type present (41,109,131,147). Moreover, several untypable SCCmec elements have 
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been found in LA-MRSA but it is unknown exactly how many different elements LA-MRSA 
carries. In addition, since LA-MRSA has been detectd in a large geographical area and in 
many different species, the acquisition of SCCmec could have occurred in different species 
and different countries. However, until now ST398 MSSA has only been reported from the 
Cape Verde islands (41), France (147), the United Sates and the Dominican Republic (177) 
and was found only in humans (41,147,177) and pigs (147). 
In conclusion, the origin and evolution of LA-MRSA following acquisition of different 
SCCmec elements by different MSSA ST398 strains involves many unanswered questions, 
which for the moment can only be addressed with speculations. The lack of long-term data on 
the presence of S. aureus in pigs - MSSA as well as MRSA and human as well as non-human 
strains - makes it reasonable to fear many of these questions will remain unanswered. 
 
Acquisition of Panton-Valentine leukocidin 
In addition to the SCCmec issues, another event that deserves consideration whe trying to 
unravel the molecular evolution of LA-MRSA is the acquisition by certain strains of the genes 
encoding the Panton-Valentine leukocidin (PVL). Strains of CC398 MRSA that did possess 
the PVL genes have been found causing human infections in China (140) and Sweden (186). 
However, the large majority of CC398 MRSA strains that have been investigated appeared 
not to possess these genes, even when the strains oiginated from infections (e.g. 
116,119,130,134,149,187).  
It is not clear how the aforementioned LA-MRSA strains acquired PVL. The genes encoding 
PVL are carried on mobile genetic elements (MGEs) (188). As both cases reported no link 
between the patients and animal contact but instead found medical histories of the patients 
that are typical for HA-MRSA (140) and CA-MRSA (140,186), perhaps it concerned LA-
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MRSA strains that resided already for a longer period in the hospital or the community 
environment and acquired PVL from human MRSA strains.  
Despite the fact that the importance of PVL as virulence factor is still controversial 
(88,89,91,94), these cases illustrate the potential of LA-MRSA to take up virulence factors on 
MGEs. A further spread of such MGEs in LA-MRSA may impose a serious risk for both 
human and animal health, seen the wide spread of LA-MRSA in some animals and its 
potential to colonize and infect humans.  
 
LA-MRSA in humans 
Since the medical significance of LA-MRSA for veterinary medicine is currently rather low, 
perhaps the most worrying aspect of LA-MRSA is its apparent capacity to transfer between its 
animal carriers and people in close contact with them. This has been extensively shown in pig 
farming. Several studies, from many different countries, found that living or working on a 
farm with colonized pigs were risk factors for LA-MRSA carriage 
(109,116,121,123,132,133,149). In the Netherlands, an increased risk of LA-MRSA carriage 
has also been shown in veal calf farming (114,116,189,190), even though actual carriage of 
LA-MRSA by veal calves has been reported only once (114). An increased risk has not yet 
been shown for dairy or meat cattle farmers. To a lesser extent, also poultry farmers have 
been found colonized as a result of LA-MRSA carriage by their animals (113). In addition, 
also veterinarians working with pigs and cattle were found to be at higher risk for carriage of 
LA-MRSA (109,110,116,122,123).  
Despite the fact that its transferring capacity waspretty clear from the first reports on LA-
MRSA (109,131), until today, many features concerning it remain unclear. For example, as 
such an extensive transfer between humans and animals has not been reported for any other 
clone of MRSA, it can be assumed that LA-MRSA posses es special mechanisms or 
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characteristics. However, this assumption has not yet been verified, and consequently, 
possible mechanisms have not yet been elucidated. Furthermore, only little information is 
available on actual risk factors and associated transmission routes. Equal to other HA-MRSA 
and CA-MRSA, the most obvious risk factor and route of transmission of LA-MRSA is direct 
contact with colonized patients, i.c. animals. This ha  been proven in pig and veal calf 
farming (116,190). Yet, though it can be assumed to be important also in other animal 
farming activities, so far this has not been substantiated with evidence. Further, the duration 
of animal contact and the percentage of MRSA positive animals were shown to be risk factors 
in veal calf farming. In addition, contact with a contaminated environment has been suggested 
(174). Such environment could also include the air, as studies have shown that air in pig and 
cow stables may contain considerable amounts of (antimicrobial resistant) bacteria (191,192). 
This has however not been investigated for LA-MRSA.  
In general, more research is urgently needed to gain further information on risk factors and 
transmission routes of LA-MRSA. This is an essential requirement for efficient control 
measures to be implemented. This is of particular importance, since, in addition to its capacity 
to colonize humans, LA-MRSA has also been found capable to cause infections in humans. 
LA-MRSA has been isolated from (severe) infections f people in close contact with pigs 
(116,132,134,187,193,194) and poultry (130) (Table 4). There seems to be no association of 
LA-MRSA with certain clinical conditions, as it has been found in both invasive and skin 
related infections (Table 4). In addition, it is not clear whether a decreased human health 
condition predisposes to development of LA-MRSA infections. Further, as has been noted for 
animal infections with LA-MRSA, it is currently totally unclear which virulence factors are of 
importance in human LA-MRSA infections. However, for now, it seems that the virulence 
capacity and associated medical importance of LA-MRSA is much lower compared with 
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traditional human HA- and CA-MRSA strains. Nonetheless, future research should urgently 
bring more insight in these matters. 
Another important aspect of LA-MRSA in humans is that, although infrequently reported and 
not (yet) substantiated by epidemiological data, LA-MRSA appears to be capable to transfer 
between humans. In the Netherlands, a six-months-old daughter of pig farmers, who 
presumably had not had direct contact with pigs, appe red colonized (109). In that same 
study, the son of a veterinarian and the nurse treating the son in the hospital to which he was 
admitted also appeared to be carrying LA-MRSA (109). This could create very dangerous 
situations, especially when personnel of medical settings carry LA-MRSA. In a Dutch 
hospital, a case was reported in which five healthcre workers and three patients appeared to 
carry LA-MRSA and two other patients were infected by LA-MRSA (133). Recently, also in 
a residential care facility for visually and intellectually disabled people a resident was 
diagnosed with dermal abscesses caused by LA-MRSA. Subsequent research revealed two 
other residents and three personnel members to be carrying LA-MRSA (138). 
Contrary to what these cases suggest, LA-MRSA seems not to be able to spread widely in the 
community or in hospital settings. LA-MRSA has been known in hospitals for several years 
but still no large spread has been reported. Nonetheless, it is clear that LA-MRSA could 
complicate the MRSA control measures for hospital settings, particularly in countries that 
perform strict control measures, such as the Netherlands (195). Not only will the group of risk 
patients expand considerably, implying a higher number of screenings to be done on 
admission to a hospital, a higher number of screenings is also likely to lead to more people 
that need to be kept in isolation, implying a serious burden for hospital accommodations and 
healthcare means. That this problem is very relevant w s shown by a recent Dutch study, in 
which it was found that the inclusion of the new risk group of animal farmers had lead to a 3-




MRSA in livestock should be regarded from two sides: CC398 MRSA and non-CC398 
MRSA. The few reports of non-CC398 MRSA in pigs and poultry concerned MRSA of 
human origin. There are no indications that these anim ls play a role as reservoir for 
reinfection of humans nor that this will change in the near future. The situation in cattle is 
more complex. Non-CC398 MRSA is detected more frequently than in pigs and poultry, 
almost solely from mastitis, indicating a problem for animal health. However, the size of the 
problem is hard to assess. Quarter-level prevalence seems to be very low but cow-level and 
farm-level prevalence cannot be estimated due to a lack of consistent data. 
Meat and milk are occasionally found to be contaminated with (human) non-CC398 MRSA 
strains. Although these food products have not yet be n found to contribute to the 
dissemination of such strains in the community, care must be taken when drawing 
conclusions, due to a lack of thorough research. Until more studies have been performed 
normal hygiene measures and adequate preparation of the foods should suffice to contain this 
situation. This also counts regarding the recent detection of CC398 MRSA on various meat 
products. 
CC398 MRSA or LA-MRSA seems primarily associated with pigs but its origin is still largely 
unclear. Strains of this clone have spread around the world. In livestock, besides pigs also 
cows and poultry are affected. However, the origin and relevance of LA-MRSA in the latter 
animals remains unknown to date. The implication of LA-MRSA in animal infections may 
pose a burden on veterinary medicine but to what extent is still unclear, as are the factors 
responsible for the pathogenic potential of LA-MRSA.  
An essential aspect of LA-MRSA is its remarkable degre  of host unspecificity, transferring 
also between animals and humans. Possible mechanisms explaining this host unspecificity are 
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yet to be revealed. In comparison to the extent of other types of MRSA, the impact on human 
healthcare is still small. However, the demonstration of the capacity of LA-MRSA to take-up 
toxin genes should urge the medical world to take measures to control transmission and 
spread as quickly as possible. This will require thorough research to be performed to elucidate 
transmission routes and risk factors. 
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Table 1. Summary of SCCmec1-types currently described in methicillin-resistant S. aureus. 
Class of mec-complex Type of ccr-complex SCCmec-type Approx. size Reference 
B A1/B1 I 34 kbp 30 
A A2/B2 II 53 kbp 30 
A A3/B3 III 67 kbp 30 
B A2/B2 IV 21-24 kbp 31 
C2 C V 28 kbp 32 
B A4/B4 VI 24 kbp 33 
C1 C VII 27 kbp 34 
A A4/B4 VIII  32 kbp 35 
1 SCCmec: staphylococcal cassette chromosome mec
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Table 2. Repeats of 25 spa1-types reported to belong to CC398 MRSA2 strains.  
spa-type Repeats Reference 
t011   08-16---------02-25-----------------34-------------24-25 110 
t034   08-16---------02-25---------02-25-34----------24-25 110 
t108   08-16---------02---------------------34-----------24-25 109 
t567   08-------------02-25-------------------------------24-25 109 
t571   08-16---------02-25---------02-25-34--------------25 116 
t779   08----------------------------------------------------------- 137 
t898   08-16---------02-25---------02-25-34--------34-24-25 116 
t943   08-16---------02-25-------------25-----------------24-25 109 
t1197   08-16---------02-25-----------------46-------------24-25 119 
t1250   08-16---------02-25---------02-25--------------------- 131 
t1254 106-16---------02-25-----------------34-------------24-25 111 
t1255   08-16---------------------------------34-----------24-25 121 
t1451   08-16---------02-25-----------------34----------------25 137 
t1456   08-16---------02-25-------------------------------------- 124 
t1457   08-16---------02-25-----34-02-25-34-------------24-25 137 
t2346   08-16---------02-25-----------------34-24--- ----24-25 134 
t2383   08-16-------------------------------------------------------- 138 
t2970   08-16---------02-25-----------------34---------34-24-25 137 
t3015   08-------------02-25---------------------24---------24-25 137 
t3119   08-85---------02-25-----------------34-------------24-25 137 
t4208   08-16---------02-31-------------25-34----------24-25 137 
t4872   08-16---------02-25-----------------34-24-25-34-24-25 125 
t337   07-16-23-23-02-12-23-----02-----34---------------- 116 
 53 
t899   07-16-23-----02---------------------34-------------------- 122 
t1939   07-----23-----02---------------------34------------------ 136 
1 spa: gene encoding Staphylococcus protein A  
2 MRSA: methicillin-resistant Staphylococcus aureus 
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AAAGAAGACGGCAACAAACCTGGT 
AAAGAAGACGGCAATAAACCTGGT 
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Table 4. Human infections caused by LA-MRSA1. 
Site of infection Type of infection Reference 
Heart Endocarditis 130 
Wound Diabetic foot ulcer 133 
 Infection of pig bite wound  187,193 
 Unspecified  119 
Skin Abscess 138,143,194 
 Cellulitis 194 
 Unspecified 119,132 
Respiratory tract Sinusitis 132 
 Ventilator-associated pneumonia 119 
Muscles Pyomyositis 194 
Unspecified Invasive infection with multiorgan failure 132 
Various Various 134 
1 LA-MRSA: livestock-associated methicillin-resistan Staphylococcus aureus 
